Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Your eligibility depends more on how you feel and your overall health status than the medication itself
If you experience intolerable side effects, you started too high
Do not use if you or a family member has had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
A 12-month commitment is required, but the highly praised community approach drives strong member results
Novo Nordisk agonist shows strong trial results as MASH cases rise among US adults For the first time, a GLP-1 therapy has been cleared to treat metabolic dysfunction-associated steatohepatitis (MASH), after the US Food and Drug Administration (FDA) granted accelerated approval to Novo Nordisks weight-loss drug Wegovy
US$ 24.01
US$ 29.37
US$ 29.49
